Disclosures for "A Double-Blind, Sham Controlled Study of Transcranial Photobiomodulation (PBM) in Parkinsons Disease")
-
Dr. Liebert has received personal compensation for serving as an employee of Symbyx Pty Ltd. Dr. Liebert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SymByx Pty Ltd. Dr. Liebert has stock in SymByx Pty Ltd. The institution of Dr. Liebert has received research support from Gardos family Trust.
-
Dr. Herkes has received personal compensation in the range of $0-$499 for serving as a Consultant for Symbyx. Dr. Herkes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Symbyx. Dr. Herkes has stock in Symbyx.
-
Ms. McGee has nothing to disclose.
-
Dr. Bicknell has received personal compensation for serving as an employee of SymByx Pty Ltd. Dr. Bicknell has stock in SymByx. Pty Ltd.
-
Hosen Kiat has nothing to disclose.
-
Craig McLachlan has nothing to disclose.